salvinorin a has been researched along with methysergide in 2 studies
Studies (salvinorin a) | Trials (salvinorin a) | Recent Studies (post-2010) (salvinorin a) | Studies (methysergide) | Trials (methysergide) | Recent Studies (post-2010) (methysergide) |
---|---|---|---|---|---|
247 | 7 | 128 | 2,935 | 81 | 80 |
Protein | Taxonomy | salvinorin a (IC50) | methysergide (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.0021 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 1.631 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.807 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 4.763 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.054 | |
D(1A) dopamine receptor | Homo sapiens (human) | 0.943 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.013 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0021 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.054 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.172 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0006 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.162 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bandyopadhyaya, A; Rajagopalan, DR; Rajagopalan, P; Rajagopalan, R | 1 |
Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
2 other study(ies) available for salvinorin a and methysergide
Article | Year |
---|---|
The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.
Topics: Benzodiazepinones; Isomerism; Protein Binding; Protein Structure, Tertiary; Receptors, Cell Surface | 2014 |
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |